Direct measurement of free copper in serum or plasma ultrafiltrate

American Journal of Clinical Pathology

Volumn 131, Issue 2, 2009, Pages 160-165

  McMillin, Gwendolyn A ^a,b,d   Travis, James J ^b   Hunt, John W ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c ARUP LABORATORIES   (United States)

^d NONE   (United States)

Author keywords

Ceruloplasmin; ICP MS; Inductively coupled mass spectrometry; Wilson disease

Indexed keywords

CERULOPLASMIN; COPPER;

ADULT; ANALYTIC METHOD; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BLOOD DONOR; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL LABORATORY; CONTINUING EDUCATION; CONTROLLED STUDY; COPPER BLOOD LEVEL; FEMALE; HUMAN; LABORATORY TEST; MALE; MASS SPECTROMETRY; MEASUREMENT; PLASMA; PRIORITY JOURNAL; REFERENCE VALUE; SERUM; ULTRAFILTRATION; WILSON DISEASE; BLOOD; CHEMISTRY; MIDDLE AGED; REPRODUCIBILITY; VALIDATION STUDY;

ADULT; CERULOPLASMIN; COPPER; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PLASMA; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; ULTRAFILTRATION; YOUNG ADULT;

EID: 58849122810     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP7Z9KBFINVGYF     Document Type: Article

References (22)

1. Bogden JD, Klevay LM, eds. Clinical Nutrition of the Essential Trace Elements and Minerals. Totowa, NJ: Humana Press: 2000.
2. Chan A, Wong F, Arumanayagam M. Serum ultrafiltrable copper, total copper and caeruloplasmin concentrations in gynaecological carcinomas. Ann Clin Biochem. 1993;30(pt 6):545-549.
3. Twomey PJ, Viljoen A, House IM, et al. Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin- bound copper in routine clinical practice. Clin Chem. 2005;51:1558-1559.
4. Kagan VE, Tyurin VA, Borisenko GG, et al. Mishandling of copper by albumin: role in redox-cycling and oxidative stress in preeclampsia plasma. Hypertens Pregnancy. 2001;20:221-241.
5. Pfeil SA, Lynn DJ. Wilson's disease: copper unfettered. J Clin Gastroenterol. 1999;29:22-31.
6. Nuttall KL, Palaty J, Lockitch G. Reference limits for copper and iron in liver biopsies. Ann Clin Lab Sci. 2003;33:443-450.
7. Babiloni C, Squitti R, Del Percio C, et al. Free copper and resting temporal EEG rhythms correlate across healthy, mild cognitive impairment, and Alzheimer's disease subjects. Clin Neurophysiol. 2007;118:1244-1260.
8. Squitti R, Ventriglia M, Barbati G, et al. "Free" copper in serum of Alzheimer's disease patients correlates with markers of liver function. J Neural Transm. 2007;114:1589-1594.
9. Walshe JM. Diagnosis and treatment of presymptomatic Wilson's disease. Lancet. 1988;2:435-437.
10. Langner C, Denk H. Wilson disease. Virchows Arch. 2004;445:111-118.
11. Margarit E, Bach V, Gómez D, et al. Mutation analysis of Wilson disease in the Spanish population: identification of a prevalent substitution and eight novel mutations in the ATP7B gene. Clin Genet. 2005;68:61-68.
12. Yuzbasiyan-Gurkan V, Johnson V, Brewer GJ. Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis. J Lab Clin Med. 1991;118:458-465.
13. Gow PJ, Smallwood RA, Angus PW, et al. Diagnosis of Wilson's disease: an experience over three decades. Gut. 2000;46:415-419.
14. Faa G, Nurchi V, Demelia L, et al. Uneven hepatic copper distribution in Wilson's disease. J Hepatol. 1995;22:303-308.
15. Ludwig J, Moyer TP, Rakela J. The liver biopsy diagnosis of Wilson's disease: methods in pathology. Am J Clin Pathol. 1994;102:443-446.
16. Stuerenburg HJ. CSF copper concentrations, blood- brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease. J Neural Transm. 2000;107:321-329.
17. Hartard C, Weisner B, Dieu C, et al. Wilson's disease with cerebral manifestation: monitoring therapy by CSF copper concentration. J Neurol. 1993;241:101-107.
18. Macintyre G, Gutfreund KS, Martin WR, et al. Value of an enzymatic assay for the determination of serum ceruloplasmin. J Lab Clin Med. 2004;144:294-301.
19. McMillin GA, Travis JJ, Owen WE, et al. Evaluation of the reference interval for free (nonceruloplasmin-bound) serum copper [abstract]. Am J Clin Pathol. 2004;122:462. Abstract 30.
20. Bohrer D, Do Nascimento PC, Ramirez AG, et al. Comparison of ultrafiltration and solid phase extraction for the separation of free and protein-bound serum copper for the Wilson's disease diagnosis. Clin Chim Acta. 2004;345:113-121.
21. Nilsson UA, Bassen M, Sävman K, et al. A simple and rapid method for the determination of "free" iron in biological fluids. Free Radic Res. 2002;36:677-684.
22. Ogihara H, Ogihara T, Miki M, et al. Plasma copper and antioxidant status in Wilson's disease. Pediatr Res. 1995;37:219-226.